RBC Capital Markets Raises Price Target on Repligen Corporation
RBC Capital Markets increased its price target for Repligen Corporation from $185 to $200 while maintaining an "Outperform" rating.
Stocks · News reference
Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
Repligen Corporation reported third-quarter 2026 revenue of $209 million and raised its full-year 2026 revenue guidance to $844–$852 million.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Repligen Q3 2026 Earnings Call Transcript
Repligen (NASDAQ:RGEN) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
8-K filing — REPLIGEN CORP (RGEN)
Filed: 2026-10-27 AccNo: 0001628280-26-067405 Size: 547 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits